Anandamide enhances IL‐10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF‐κB
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The endocannabinoid system exhibits anti‐inflammatory properties by regulating cytokine production. Anandamide (AEA) down‐regulates proinflammatory cytokines in a viral model of multiple sclerosis (MS). However, little is known about the mechanisms by which AEA exerts these effects. Microglial cells are the main source of cytokines within the brain and the first barrier of defense against pathogens by acting as antigen presenting cells. IL‐10 is a key physiological negative regulator of microglial activation. In this study we show that AEA enhances LPS/IFNγ‐induced IL‐10 production in microglia by targeting CB 2 receptors through the activation of ERK1/2 and JNK MAPKs. AEA also inhibits NF‐κB activation by interfering with the phosphorylation of IκBα, which may result in an increase of IL‐10 production. Moreover, endogenously produced IL‐10 negatively regulates IL‐12 and IL‐23 cytokines, which in its turn modify the pattern of expression of transcription factorsinvolved in Th commitment of splenocytes. This suggeststhat by altering the cytokine network, AEA could indirectly modify the type of immune responses within the central nervous system (CNS). Accordingly, pharmacological modulation of AEA uptake and degradation might be a useful tool for treating neuroinflammatory diseases. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 2×
“In conclusion, AEA targeting microglia drives the blockade of essential cytokines that support Th1 responses in the case of IL-12p70 or Th-17 cell expansion/maintenance in the case of IL-23 (Bettelli et al., 2006), together with the enhancement of a cytokine that favor Th2 responses, such as IL-10.”
BackgroundNF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918 · cited 1×
“Activation of the NF-jB/Rel transcription family plays a central role in inflammation and exerts pleiotropic actions in numerous cellular responses (Tak and Firestein, 2001).”
BackgroundMicroglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 1×
“Microglia, the brain-resident immune cells are activated in most pathological conditions of the central nervous system (CNS) and participate in the regulation of innate and adaptive immune responses (Hanisch and Kettenmann, 2007).”
BackgroundEljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.11.027 · Cited by 445 · cited 3×
“tects neurons from inflammatory damage (Eljaschewitsch et al., 2006).”
BackgroundBenito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256
Self-citationAnandamide Inhibits Nuclear Factor-κB Activation through a Cannabinoid Receptor-Independent Pathway
Sancho, R., Calzado, M. A., Di Marzo, V., Appendino, G., & Muñoz, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.429 · Cited by 120
Carter, A. B., & Hunninghake, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003599200 · Cited by 119
Cited by
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
The role of the immune system in the generation of neuropathic pain
Calvo, M., Dawes, J. M., & Bennett, D. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70134-5 · Cited by 445
Balancing the immune response in the brain: IL-10 and its regulation
Lobo-Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 429
Merighi, S., Gessi, S., Varani, K., Fazzi, D., Mirandola, P., & Borea, P. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01948.x · Cited by 79
“It is known that the anti-inflammatory properties of CB receptor agonists are expressed through the activation of CB2 receptors (Klein and Newton, 2007; Romero-Sandoval et al., 2009; Correa et al., 2010; Hsieh et al., 2011).”
BackgroundDing, J., Li, Q., Wang, X., Sun, C., Lu, C., & Xiao, B. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06876.x · Cited by 79
Metadata
- Authors
- Correa, F., Hernangómez, M., Mestre, L., Loría, F., Spagnolo, A., Docagne, F., Di Marzo, V., & Guaza, C.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2009-06-29
- Volume
- 58
- Issue
- 2
- Pages
- 135-147
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2047581866
- Cited by
- 181
- References
- 7
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anandamide enhances IL‐10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF‐κB. https://app.cochat.ai/papers/10.1002/glia.20907
- The paper
- Correa, F., Hernangómez, M., Mestre, L., Loría, F., Spagnolo, A., Docagne, F., Di Marzo, V., & Guaza, C. (2010). Anandamide enhances IL‐10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF‐κB. Glia. https://doi.org/10.1002/glia.20907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.